CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
84 hedge funds and large institutions have $1.29B invested in China Biologic Products Holdings, Inc. in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 28 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 87 → 84 (-3)
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
Holders
84
Holding in Top 10
7
Calls
$29.8M
Puts
$6.06M
Top Buyers
| 1 | +$44M | |
| 2 | +$41.9M | |
| 3 | +$22.2M | |
| 4 |
Millennium Management
New York
|
+$13.7M |
| 5 |
BP
BFAM Partners
Northpoint, Hong Kong,
Hong Kong
|
+$13.7M |
Top Sellers
| 1 | -$27.1M | |
| 2 | -$23.1M | |
| 3 | -$15.3M | |
| 4 |
Goldman Sachs
New York
|
-$9.58M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$4.14M |